$359 Million is the total value of Graypoint LLC's 151 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MUB | ISHARES NATIONAL MUNI BOND ETFetf | $2,077,000 | +2.1% | 18,000 | 0.0% | 0.47% | -16.6% | |
| ORCC | OWL ROCK CAPITAL CORPORATION COMcef | $1,036,000 | +6.9% | 84,020 | 0.0% | 0.24% | -12.6% | |
| EFV | ISHARES MSCI EAFE VALUE ETFetf | $736,000 | +12.0% | 18,413 | 0.0% | 0.17% | -8.2% | |
| IWR | ISHARES RUSSELL MID-CAP ETFetf | $638,000 | +24.1% | 11,908 | 0.0% | 0.14% | +1.4% | |
| BRKA | BERKSHIRE HATHAWAY INC DEL CL Astock | $535,000 | -1.7% | 2 | 0.0% | 0.12% | -19.7% | |
| WFCPRL | WELLS FARGO CO NEW PERP PFD CNV Aconvertible preferred | $511,000 | +2.0% | 394 | 0.0% | 0.12% | -17.1% | |
| SPYD | SPDR PORTFOLIO S&P 500 HIGH DIVIDEND ETFetf | $460,000 | +13.3% | 16,531 | 0.0% | 0.10% | -7.1% | |
| VFMO | VANGUARD U.S. MOMENTUM FACTOR ETFetf | $415,000 | +27.3% | 4,833 | 0.0% | 0.10% | +4.4% | |
| REGN | REGENERON PHARMACEUTICALS COMstock | $413,000 | +27.9% | 662 | 0.0% | 0.09% | +4.4% | |
| VB | VANGUARD SMALL-CAP INDEX FUNDetf | $345,000 | +26.4% | 2,365 | 0.0% | 0.08% | +3.9% | |
| VGK | VANGUARD FTSE EUROPE ETFetf | $341,000 | +16.8% | 6,767 | 0.0% | 0.08% | -3.7% | |
| VFVA | VANGUARD U.S. VALUE FACTOR ETFetf | $336,000 | +25.4% | 5,674 | 0.0% | 0.08% | +2.7% | |
| AGG | ISHARES CORE U.S. AGGREGATE BOND ETFetf | $301,000 | +2.7% | 2,545 | 0.0% | 0.07% | -15.9% | |
| PHYS | SPROTT PHYSICAL GOLD TR UNITcef | $296,000 | +9.2% | 20,679 | 0.0% | 0.07% | -11.8% | |
| SUSA | ISHARES MSCI USA ESG SELECT ETFetf | $288,000 | +22.0% | 2,154 | 0.0% | 0.07% | 0.0% | |
| IWP | ISHARES RUSSELL MID-CAP GROWTH ETFetf | $284,000 | +30.3% | 1,794 | 0.0% | 0.06% | +6.6% | |
| HYG | ISHARES IBOXX $ HIGH YIELD CORPORATE BOND ETFetf | $252,000 | +5.9% | 3,093 | 0.0% | 0.06% | -13.6% | |
| ETB | EATON VANCE TAX MNGED BUY WRIT COMcef | $245,000 | +15.0% | 17,547 | 0.0% | 0.06% | -5.1% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-07-30
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 ETF TRUST | 18 | Q2 2024 | 6.5% |
| ISHARES CORE S&P 500 ETF | 18 | Q2 2024 | 6.7% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 18 | Q2 2024 | 7.0% |
| ISHARES RUSSELL 1000 GROWTH ETF | 18 | Q2 2024 | 4.8% |
| APPLE INC COM | 18 | Q2 2024 | 3.8% |
| TECHNOLOGY SELECT SECTOR SPDR FUND | 18 | Q2 2024 | 4.5% |
| HEALTH CARE SELECT SECTOR SPDR FUND | 18 | Q2 2024 | 4.2% |
| NVIDIA CORPORATION COM | 18 | Q2 2024 | 3.8% |
| ISHARES S&P MIDCAP FUND | 18 | Q2 2024 | 2.9% |
| ISHARES S&P SMALL-CAP FUND | 18 | Q2 2024 | 2.7% |
View Graypoint LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-29 |
| 13F-HR | 2024-07-31 |
| 13F-HR | 2024-05-02 |
| 13F-HR | 2024-01-29 |
| 13F-HR | 2023-10-26 |
| 13F-HR | 2023-07-21 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-01-31 |
| 13F-HR | 2022-10-31 |
| 13F-HR | 2022-08-01 |
View Graypoint LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.